Brian T. Crum - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$44,565
Form type
4
Date filed
3/1/2023, 03:49 PM
Previous filing
Feb 13, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +21K +21.14% 120K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +8.75K +7.26% 129K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +26.1K +20.19% 155K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$44.6K -20.5K -13.22% $2.17 135K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -21K -100% 0 Feb 28, 2023 Common Stock 21K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -8.75K -50% 8.75K Feb 28, 2023 Common Stock 8.75K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -26.1K -33.33% 52.2K Feb 28, 2023 Common Stock 26.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.